<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Of 187 specimens of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and four hyperplastic lymphoid proliferations with clonal chromosome abnormalities ascertained serially over a 4 1/2-year period, nine cases with t(3;22)(q27;q11) were identified </plain></SENT>
<SENT sid="1" pm="."><plain>Seven of the <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were diffuse <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, predominantly large cell type </plain></SENT>
<SENT sid="2" pm="."><plain>The eighth <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, a follicular small cleaved cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, exhibited a t(3;22) and a t(14;18)(q32;q21) </plain></SENT>
<SENT sid="3" pm="."><plain>The ninth case was a lymph node from a human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus-positive patient which showed <z:mpath ids='MPATH_483'>atypical hyperplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Overall survival of t(3;22) diffuse <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients was not different from that of patients with abnormal karyotypes without t(3;22) </plain></SENT>
<SENT sid="5" pm="."><plain>The t(3;22) diffuse <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> studied showed a disproportionate frequency of lambda light chain on their cell surfaces, a finding similar to that observed in t(8;22)(q24;q11) Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Our results indicate that the t(3;22)(q27;q11) is the third most common recurring translocation in diffuse non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>